RDUS vs. TSLA

In the year-to-date period, RDUS achieves a -15.55% return, which is significantly lower than TSLA's -11.89% return. Over the past 10 years, RDUS has underperformed TSLA with an annualized return of 0.79%, while TSLA has yielded a comparatively higher 38.21% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Radius Health, Inc. (RDUS) and Tesla, Inc. (TSLA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current RDUS Sharpe Ratio is -0.70, which is lower than the TSLA Sharpe Ratio of 1.45. The chart below compares the historical Sharpe Ratios of RDUS and TSLA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

RDUS's dividend yield for the trailing twelve months is around 6.01%, while TSLA has not paid dividends to shareholders.

The maximum RDUS drawdown since its inception was -88.18%, which is greater than TSLA's maximum drawdown of -73.63%. Use the drawdown chart below to compare losses from any high point for RDUS and TSLA. For additional features, visit the drawdowns tool.

Radius Health, Inc. (RDUS) has a higher volatility of 15.66% compared to Tesla, Inc. (TSLA) at 13.77%. This indicates that RDUS's price experiences larger fluctuations and is considered to be riskier than TSLA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Radius Health, Inc. and Tesla, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.